Exicure (XCUR) Operating Leases (2019 - 2025)
Exicure's (XCUR) quarterly Operating Leases came in at $27000.0 in Q1 2025, down 99.54% YoY from $5.8 million in Q1 2024, and down 99.48% on a QoQ basis from $5.2 million in Q4 2024.
Exicure (XCUR) Operating Leases (2019 - 2025) Analysis & Trends
Exicure (XCUR) has 7 years of Operating Leases data on file, last reported at $27000.0 in Q1 2025.
- Quarterly Operating Leases fell 99.54% year-over-year to $27000.0 in Q1 2025, while the trailing twelve-month figure through Mar 2025 was $27000.0 (down 99.54% YoY) and the FY2024 annual result came in at $5.2 million, down 13.68% from the prior year.
- Operating Leases fell to $27000.0 in Q1 2025, from $5.2 million in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $8.2 million in Q1 2021 to a low of $27000.0 in Q1 2025.
- A 5-year average of $6.3 million and a median of $6.6 million in 2023 frame the typical range for Operating Leases.
- Annual changes were most pronounced in 2021 — Operating Leases dropped 1.19% — and 2025, when it plunged 99.54%.
- Tracing XCUR's Operating Leases over 5 years: stood at $7.4 million in 2021, then fell by 8.6% to $6.8 million in 2022, then decreased by 10.76% to $6.0 million in 2023, then dropped by 13.68% to $5.2 million in 2024, then sank by 99.48% to $27000.0 in 2025.
- The last three Operating Leases figures came in at $27000.0 (Q1 2025), $5.2 million (Q4 2024), and $5.4 million (Q3 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Exicure | 7.27 Mn | 7.27 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 27,000.00 |
| Dec 31, 2024 | 5.21 Mn |
| Sep 30, 2024 | 5.43 Mn |
| Jun 30, 2024 | 5.64 Mn |
| Mar 31, 2024 | 5.84 Mn |
| Dec 31, 2023 | 6.04 Mn |
| Sep 30, 2023 | 6.23 Mn |
| Jun 30, 2023 | 6.42 Mn |
| Mar 31, 2023 | 6.60 Mn |
| Dec 31, 2022 | 6.77 Mn |
| Sep 30, 2022 | 6.94 Mn |
| Jun 30, 2022 | 7.10 Mn |
| Mar 31, 2022 | 7.25 Mn |
| Dec 31, 2021 | 7.40 Mn |
| Sep 30, 2021 | 7.99 Mn |
| Jun 30, 2021 | 8.12 Mn |
| Mar 31, 2021 | 8.16 Mn |
| Dec 31, 2020 | 7.96 Mn |
| Sep 30, 2020 | 8.09 Mn |
| Dec 31, 2019 | 59,000.00 |